Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
5.71
-0.23 (-3.87%)
At close: Apr 3, 2025, 4:00 PM
5.99
+0.28 (4.90%)
After-hours: Apr 3, 2025, 5:30 PM EDT

Aura Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-86.92-76.41-58.76-35.25-22.21
Upgrade
Depreciation & Amortization
1.221.31.180.830.83
Upgrade
Loss (Gain) From Sale of Assets
-0.21-0.020-
Upgrade
Loss (Gain) From Sale of Investments
-4.66-3.99-0.53--
Upgrade
Stock-Based Compensation
11.728.776.412.310.74
Upgrade
Other Operating Activities
1.471.840.970.02-0
Upgrade
Change in Accounts Payable
0.48-1.040.341.05-1.72
Upgrade
Change in Other Net Operating Assets
-3.125.48-4.19-1.37-1.96
Upgrade
Operating Cash Flow
-79.81-63.85-54.6-32.41-24.32
Upgrade
Capital Expenditures
-1.25-0.71-1.09-2.13-0.77
Upgrade
Investment in Securities
70.07-113.25-66.78--
Upgrade
Investing Cash Flow
68.82-113.96-67.87-2.13-0.77
Upgrade
Issuance of Common Stock
1.697.2995.6379.050.16
Upgrade
Other Financing Activities
----0.02-0.03
Upgrade
Financing Cash Flow
1.697.2995.63166.2610.04
Upgrade
Net Cash Flow
-9.39-80.52-26.84131.72-15.06
Upgrade
Free Cash Flow
-81.06-64.56-55.7-34.54-25.09
Upgrade
Free Cash Flow Per Share
-1.63-1.63-1.86-6.69-68.33
Upgrade
Levered Free Cash Flow
-50.17-39.34-33.69-20.52-16.74
Upgrade
Unlevered Free Cash Flow
-50.17-39.34-33.69-20.52-16.73
Upgrade
Change in Net Working Capital
1.79-4.422.5-0.53.65
Upgrade
Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q